A new drug described as “the closest we have ever been to an HIV vaccine” could be sold for $40 a year and still make 30% profit, but is currently being sold by pharma companies for $42,250. Absolutely criminal.
https://www.theguardian.com/global-development/article/2024/jul/23/hiv-aids-prevention-vaccine-lenacapavir-sunlenca-pharmaceuticals-gilead-generic-licensing
Dr. Lucky Tran :verified:
npub1fv…rnhwd
2024-07-23 21:13:28 UTC
Author Public Key
npub1fvus6ey0wswu2y4mfycc7h5ckz6h72h6vmhczz3lyzynjg5egdlqdrnhwdPublished at
2024-07-23 21:13:28 UTCEvent JSON
{
"id": "4914c9dce79201322a1202ce5221168daef2e8dc752d70bed9e6299da8a07648",
"pubkey": "4b390d648f741dc512bb49318f5e98b0b57f2afa66ef810a3f2089392299437e",
"created_at": 1721769208,
"kind": 1,
"tags": [
[
"proxy",
"https://med-mastodon.com/users/luckytran/statuses/112837866844072519",
"activitypub"
]
],
"content": "A new drug described as “the closest we have ever been to an HIV vaccine” could be sold for $40 a year and still make 30% profit, but is currently being sold by pharma companies for $42,250. Absolutely criminal. \n\nhttps://www.theguardian.com/global-development/article/2024/jul/23/hiv-aids-prevention-vaccine-lenacapavir-sunlenca-pharmaceuticals-gilead-generic-licensing",
"sig": "483e0569485203f0b8c8172a962185881d4b14ee066af2f4423b3b69847301384a070a0b3b3d00cab1bc2198152d578f5a7255386680e068325fcd8162f7463f"
}